2003
DOI: 10.1007/s00535-003-1114-y
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of gastric peristalsis inhibition by scopolamine butylbromide and glucagon: evaluation by electrogastrography and analysis of heart rate variability

Abstract: Inhibition of gastric peristalsis by glucagon via glucagon receptors on smooth muscles did not influence autonomic nervous activity, unlike the results obtained after administration of scopolamine butylbromide. Therefore, glucagon may be safe for use with elderly patients and those with cardiopulmonary complications.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
38
1

Year Published

2006
2006
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 31 publications
(40 citation statements)
references
References 26 publications
1
38
1
Order By: Relevance
“…Although the number of studies is limited, one interesting Japanese study 14 assesses EGG activity, heart rate variability, and hormonal responses simultaneously in young healthy subjects receiving an intramuscular injection of glucagon, an endocrine polypeptide hormone with two different pharmacological activities: it antagonizes insulin and increases glucose levels and acts directly on gastrointestinal smooth muscle and inhibits peristalsis of the gastrointestinal tract. In this study, 14 the peak power amplitudes of the EGG were significantly decreased after injection of glucagons although such significant changes were not found in heart rate variability (HF and LF/HF) or serum catecholamine levels (epinephrine, norepinephrine, and dopamine). The prevalence of metabolic syndrome in a young population has been reported to be 7% in those aged 20-29 years, rising to 44% in those aged 60-69 years in the United States (National Health and Nutrition Examination Survey).…”
Section: Discussioncontrasting
confidence: 61%
See 2 more Smart Citations
“…Although the number of studies is limited, one interesting Japanese study 14 assesses EGG activity, heart rate variability, and hormonal responses simultaneously in young healthy subjects receiving an intramuscular injection of glucagon, an endocrine polypeptide hormone with two different pharmacological activities: it antagonizes insulin and increases glucose levels and acts directly on gastrointestinal smooth muscle and inhibits peristalsis of the gastrointestinal tract. In this study, 14 the peak power amplitudes of the EGG were significantly decreased after injection of glucagons although such significant changes were not found in heart rate variability (HF and LF/HF) or serum catecholamine levels (epinephrine, norepinephrine, and dopamine). The prevalence of metabolic syndrome in a young population has been reported to be 7% in those aged 20-29 years, rising to 44% in those aged 60-69 years in the United States (National Health and Nutrition Examination Survey).…”
Section: Discussioncontrasting
confidence: 61%
“…These results were unexpected because we had hypothesized that an accumulation of stress and unhealthy lifestyle factors caused the suppression of EGG activity through hyperactivity of the sympathetic nervous system or hypoactivity of the parasympathetic nervous system. 14,30 A possible explanation for our findings is that a reduction in EGG activity may have directly reflected metabolic changes, including an increase in body fat and a decrease in HDL cholesterol, rather than the effects of accelerated sympathetic nervous functioning or decreased parasympathetic nervous functioning. Altered EGG activity has been frequently observed in obese patients.…”
Section: Discussionmentioning
confidence: 73%
See 1 more Smart Citation
“…Hyoscine-N-butylbromide is associated with cardiovascular events, and glucagon can lead to delayed hypoglycemia [4,5]. Another disadvantage is that these conventional antispasmodic agents are administered by injection, inevitably causing pain.…”
Section: Introductionmentioning
confidence: 99%
“…Antispasmodic agents, such as hyoscine-N-butylbromide and glucagon, are often used to inhibit peristalsis during upper GI endoscopy [4], but they are associated with the possibility of developing serious complications. Hyoscine-N-butylbromide is associated with cardiovascular events, and glucagon can lead to delayed hypoglycemia [4,5].…”
Section: Introductionmentioning
confidence: 99%